Cargando…

PM409. Paliperidone Palmitate 3-Monthly vs. 1-Monthly Injectable in Schizophrenia Patients with or without Prior Exposure to Oral Risperidone or Paliperidone

Detalles Bibliográficos
Autores principales: Mathews, Maju, Pei, Huiling, Savitz, Adam, Nuamah, Isaac, Elefant, Erica, Hough, David, Alphs, Larry, Gopal, Srihari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616344/
http://dx.doi.org/10.1093/ijnp/pyw041.409
_version_ 1783266759930806272
author Mathews, Maju
Pei, Huiling
Savitz, Adam
Nuamah, Isaac
Elefant, Erica
Hough, David
Alphs, Larry
Gopal, Srihari
author_facet Mathews, Maju
Pei, Huiling
Savitz, Adam
Nuamah, Isaac
Elefant, Erica
Hough, David
Alphs, Larry
Gopal, Srihari
author_sort Mathews, Maju
collection PubMed
description
format Online
Article
Text
id pubmed-5616344
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56163442017-11-27 PM409. Paliperidone Palmitate 3-Monthly vs. 1-Monthly Injectable in Schizophrenia Patients with or without Prior Exposure to Oral Risperidone or Paliperidone Mathews, Maju Pei, Huiling Savitz, Adam Nuamah, Isaac Elefant, Erica Hough, David Alphs, Larry Gopal, Srihari Int J Neuropsychopharmacol Abstracts Oxford University Press 2016-05-27 /pmc/articles/PMC5616344/ http://dx.doi.org/10.1093/ijnp/pyw041.409 Text en © The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.
spellingShingle Abstracts
Mathews, Maju
Pei, Huiling
Savitz, Adam
Nuamah, Isaac
Elefant, Erica
Hough, David
Alphs, Larry
Gopal, Srihari
PM409. Paliperidone Palmitate 3-Monthly vs. 1-Monthly Injectable in Schizophrenia Patients with or without Prior Exposure to Oral Risperidone or Paliperidone
title PM409. Paliperidone Palmitate 3-Monthly vs. 1-Monthly Injectable in Schizophrenia Patients with or without Prior Exposure to Oral Risperidone or Paliperidone
title_full PM409. Paliperidone Palmitate 3-Monthly vs. 1-Monthly Injectable in Schizophrenia Patients with or without Prior Exposure to Oral Risperidone or Paliperidone
title_fullStr PM409. Paliperidone Palmitate 3-Monthly vs. 1-Monthly Injectable in Schizophrenia Patients with or without Prior Exposure to Oral Risperidone or Paliperidone
title_full_unstemmed PM409. Paliperidone Palmitate 3-Monthly vs. 1-Monthly Injectable in Schizophrenia Patients with or without Prior Exposure to Oral Risperidone or Paliperidone
title_short PM409. Paliperidone Palmitate 3-Monthly vs. 1-Monthly Injectable in Schizophrenia Patients with or without Prior Exposure to Oral Risperidone or Paliperidone
title_sort pm409. paliperidone palmitate 3-monthly vs. 1-monthly injectable in schizophrenia patients with or without prior exposure to oral risperidone or paliperidone
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5616344/
http://dx.doi.org/10.1093/ijnp/pyw041.409
work_keys_str_mv AT mathewsmaju pm409paliperidonepalmitate3monthlyvs1monthlyinjectableinschizophreniapatientswithorwithoutpriorexposuretooralrisperidoneorpaliperidone
AT peihuiling pm409paliperidonepalmitate3monthlyvs1monthlyinjectableinschizophreniapatientswithorwithoutpriorexposuretooralrisperidoneorpaliperidone
AT savitzadam pm409paliperidonepalmitate3monthlyvs1monthlyinjectableinschizophreniapatientswithorwithoutpriorexposuretooralrisperidoneorpaliperidone
AT nuamahisaac pm409paliperidonepalmitate3monthlyvs1monthlyinjectableinschizophreniapatientswithorwithoutpriorexposuretooralrisperidoneorpaliperidone
AT elefanterica pm409paliperidonepalmitate3monthlyvs1monthlyinjectableinschizophreniapatientswithorwithoutpriorexposuretooralrisperidoneorpaliperidone
AT houghdavid pm409paliperidonepalmitate3monthlyvs1monthlyinjectableinschizophreniapatientswithorwithoutpriorexposuretooralrisperidoneorpaliperidone
AT alphslarry pm409paliperidonepalmitate3monthlyvs1monthlyinjectableinschizophreniapatientswithorwithoutpriorexposuretooralrisperidoneorpaliperidone
AT gopalsrihari pm409paliperidonepalmitate3monthlyvs1monthlyinjectableinschizophreniapatientswithorwithoutpriorexposuretooralrisperidoneorpaliperidone